Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem Hanekom

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2026
Efficacy and acceptability of liraglutide for obesity in people with HIV: results of an open-label clinical trial in South AfricaNgundu Behuhuma, Gugulethu Gasa, Anne Derache, et al.
Vaccine|June 15, 2015
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic settingAdam Penn-Nicholson, Hennie Geldenhuys, Wivine Burny, et al.
Nature|August 24, 2018
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesRoshni Roy Chowdhury, Francesco Vallania, Qianting Yang, et al.
Nature|November 1, 2018
Author Correction: A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesRoshni Roy Chowdhury, Francesco Vallania, Qianting Yang, et al.
Wellcome Open Research|September 2, 2020
Protocol: Leveraging a demographic and health surveillance system for Covid-19 Surveillance in rural KwaZulu-NatalMark J Siedner, Guy Harling, Anne Derache, et al.
Elife|October 27, 2022
HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathwayRobert Krause, Jumari Snyman, Hwa Shi-Hsia, et al.
Nature|March 29, 2021
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasmaSandile Cele, Inbal Gazy, Laurelle Jackson, et al.
Elife|October 5, 2021
HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection waveFarina Karim, Inbal Gazy, Sandile Cele, et al.
BMC Public Health|August 15, 2023
Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South AfricaJacob Busang, Thembelihle Zuma, Carina Herbst, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)Khadija Khan, Gila Lustig, Mallory Bernstein, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2026
Efficacy and acceptability of liraglutide for obesity in people with HIV: results of an open-label clinical trial in South AfricaNgundu Behuhuma, Gugulethu Gasa, Anne Derache, et al.
Vaccine|June 15, 2015
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic settingAdam Penn-Nicholson, Hennie Geldenhuys, Wivine Burny, et al.
Nature|August 24, 2018
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesRoshni Roy Chowdhury, Francesco Vallania, Qianting Yang, et al.
Nature|November 1, 2018
Author Correction: A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesRoshni Roy Chowdhury, Francesco Vallania, Qianting Yang, et al.
Wellcome Open Research|September 2, 2020
Protocol: Leveraging a demographic and health surveillance system for Covid-19 Surveillance in rural KwaZulu-NatalMark J Siedner, Guy Harling, Anne Derache, et al.
Elife|October 27, 2022
HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathwayRobert Krause, Jumari Snyman, Hwa Shi-Hsia, et al.
Nature|March 29, 2021
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasmaSandile Cele, Inbal Gazy, Laurelle Jackson, et al.
Elife|October 5, 2021
HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection waveFarina Karim, Inbal Gazy, Sandile Cele, et al.
BMC Public Health|August 15, 2023
Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South AfricaJacob Busang, Thembelihle Zuma, Carina Herbst, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)Khadija Khan, Gila Lustig, Mallory Bernstein, et al.
Pageof 9